Use of avacopan in severe forms of ANCA-associated vasculitis. Comment on \"Inhibiting C5a/C5aR to treat ANCA-associated vasculitides‿ by Terrier et al. Joint Bone Spine 2023;90:105472.

0 avis

Use of avacopan in severe forms of ANCA-associated vasculitis. Comment on \"Inhibiting C5a/C5aR to treat ANCA-associated vasculitides‿ by Terrier et al. Joint Bone Spine 2023;90:105472.

Archive ouverte

Astouati, Quentin | Provot, François | Farhat, Meryem-Maud | Launay, David | Sanges, Sébastien

Edité par CCSD ; Elsevier Masson -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.

Archive ouverte | Astouati, Quentin | CCSD

Objectives To describe the characteristics of patients with Sjögren’s disease (SjD) and inclusion-body myositis (IBM), and how they compare to SjD patients with other inflammatory myopathies (IM). Methods Patients were retrospecti...

Activities of Clinical Expertise and Research in a Rare Disease Referral Centre: A Place for Telemedicine beyond the COVID-19 Pandemic?

Archive ouverte | Ducrocq, Quentin | CCSD

International audience. Introduction: Rare disease referral centres are entrusted with missions of clinical expertise and research, two activities that have to contend with numerous obstacles. Providing specialist o...

Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis.

Archive ouverte | Speca, Silvia | CCSD

International audience. Systemic sclerosis (SSc) is the most severe systemic autoimmune disease with currently no cure. Intravenous immunoglobulins (IVIg) are an attractive candidate in this disease to counteract in...

Chargement des enrichissements...